Larvol Delta - GCO-191754-Neoadjuvant-Nivolumab-With-CCR25inhibitor-or-AntiIL8-for-Nonsmall-Cell-Lung-Cancer-NSCLC-or-Hepatocellular-Carcinoma-HCC

BMS-813160 - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

BMS-986253 - BMS

http://clinicaltrials.gov/ct2/show/NCT04123379

Sep 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next